Same Indication

Insulin Glargine vs Ustekinumab

Insulin Glargine vs Ustekinumab: Overview

This comparison examines the pharmacological differences between Insulin Glargine and Ustekinumab.

Mechanism of Action

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Pharmacokinetics

Half-life: Insulin Glargine β€” 12-24 hours.

Chemical Properties

Type: Insulin Glargine β€” Protein; Ustekinumab β€” Antibody.